Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kodiak Sciences Inc.KOD · Entity 4388 | Chief Financial Officer | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kodiak Sciences Inc.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.42 · Expires 2036-07-14 | Direct | 66,500 |
Reported balance
After 2026-07-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 66,500 · Balance 66,500 F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2026; the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2026; the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2021 Filed Jun 15, 2021 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040739 · doc4.xml · derivative · entry 5 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,075 Underlying: Common Stock · 3,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F4 · derivative.exercise_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F4 · derivative.expiration_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantRestricted Stock Units · Derivative | 12,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040739 · doc4.xml · derivative · entry 4 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,100 Underlying: Common Stock · 12,100 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F4 · derivative.exercise_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F4 · derivative.expiration_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 19,250 | $0.00 Strike: $73.51 | $0.00 |
DisclosureSEC source: 0001209191-21-040739 · doc4.xml · derivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,250 Underlying: Common Stock · 19,250 shares Expires 2029-12-29 F4 · derivative.exercise_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 3,025 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-040739 · doc4.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F2 · balance_after: Includes 103 shares acquired under the 2018 Employee Stock Purchase Plan on May 31, 2021. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 22:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 805 | $131.69 | $106,009.16 |
DisclosureSEC source: 0001209191-21-020222 · doc4.xml · nonDerivative · entry 5 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,899 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $131.405 to $131.79, inclusive. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 22:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,255 | $130.82 | $164,175.46 |
DisclosureSEC source: 0001209191-21-020222 · doc4.xml · nonDerivative · entry 4 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,704 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $130.35 to $131.30, inclusive. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 22:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,031 | $129.90 | $263,831.57 |
DisclosureSEC source: 0001209191-21-020222 · doc4.xml · nonDerivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,959 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $129.30 to $130.30, inclusive. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 22:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 609 | $128.53 | $78,275.50 |
DisclosureSEC source: 0001209191-21-020222 · doc4.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,990 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $128.10 to $128.86, inclusive. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 22:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 300 | $127.08 | $38,123.01 |
DisclosureSEC source: 0001209191-21-020222 · doc4.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,599 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $126.73 to $127.34, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| June 30, 2020 Filed Jul 3, 2020 01:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantRestricted Stock Units · Derivative | 14,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040811 · doc4.xml · derivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,476 Underlying: Common Stock · 14,476 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date. Read SEC document |
| June 30, 2020 Filed Jul 3, 2020 01:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 46,163 | $0.00 Strike: $54.12 | $0.00 |
DisclosureSEC source: 0001209191-20-040811 · doc4.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,163 Underlying: Common Stock · 46,163 shares Expires 2030-06-29 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares subject to the option vests in equal monthly installments over four years measured from June 30, 2020, subject to Reporting Person's continued service on the applicable vesting date. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 22:30 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 67,500 | $0.00 Strike: $73.51 | $0.00 |
DisclosureSEC source: 0001209191-20-000402 · doc4.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2029-12-29 F1 · derivative.exercise_date: 1/48th of the shares subject to the option will vest on January 30, 2020, and 1/48th of the shares subject to the option vest on the same day of each month thereafter, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) as of each such date. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 21:48 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 67,500 | $0.00 Strike: $14.23 | $0.00 |
DisclosureSEC source: 0000899243-19-019933 · doc4.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2029-07-15 F1 · derivative.exercise_date: One forty-eighth of the shares subject to the option will vest on August 16, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter, subject to the Reporting Person's continuous service as a service provider on each such date. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 20:19 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 161,662 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0000899243-18-026302 · doc4.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,662 Underlying: Common Stock · 161,662 shares Expires 2028-10-02 F1 · derivative.exercise_date: One-sixtieth of the shares subject to the option will vest on November 3, 2018, and 1/60th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.